KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) EBITDA (2016 - 2026)

Nu Skin Enterprises' EBITDA history spans 17 years, with the latest figure at $23.2 million for Q4 2025.

  • On a quarterly basis, EBITDA rose 143.79% to $23.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $65.8 million, a 143.38% increase, with the full-year FY2025 number at $65.8 million, up 143.38% from a year prior.
  • EBITDA hit $23.2 million in Q4 2025 for Nu Skin Enterprises, up from $21.6 million in the prior quarter.
  • Over the last five years, EBITDA for NUS hit a ceiling of $85.4 million in Q2 2021 and a floor of -$125.6 million in Q2 2024.
  • Historically, EBITDA has averaged $15.4 million across 5 years, with a median of $21.0 million in 2021.
  • The widest YoY moves for EBITDA: up 169.15% in 2024, down 430.46% in 2024.
  • Tracing NUS's EBITDA over 5 years: stood at $20.3 million in 2021, then surged by 35.14% to $27.5 million in 2022, then plummeted by 41.5% to $16.1 million in 2023, then plummeted by 430.46% to -$53.1 million in 2024, then skyrocketed by 143.79% to $23.2 million in 2025.
  • Business Quant data shows EBITDA for NUS at $23.2 million in Q4 2025, $21.6 million in Q3 2025, and $30.8 million in Q2 2025.